Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × Erlotinib Hydrochloride × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 15 Pancreatic Neoplasms 6 Neoplasms 5 Lung Neoplasms 4 Head and Neck Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Melanoma 2 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Respiratory Tract Diseases 1 Parotid Neoplasms 1 Papillary renal cell carcinoma, sporadic 1 Pancreatic Intraductal Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasms, Squamous Cell 1 Neoplasms, Basal Cell 1 Multiple Myeloma 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Liver Cirrhosis 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1 Hereditary leiomyomatosis and renal cell cancer 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Carboplatin 8 pembrolizumab 6 Radiotherapy 5 Pemetrexed 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Radiation 4 Paclitaxel 3 Nivolumab 3 Cisplatin 3 Biopsy 3 fludarabine phosphate 2 durvalumab 2 aldesleukin 2 Taxes 2 Radiotherapy, Conformal 2 Platinum 2 Ipilimumab 2 Interleukin-2 2 Immunoglobulin G 2 Disulfides 2 Cyclophosphamide 2 CTLA-4 Antigen 2 Bevacizumab 2 1,2-diaminocyclohexaneplatinum II citrate 2 veliparib 1 trametinib 1 sotorasib 1 rucaparib 1 ribociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡